Related Experiment Video
Updated: Apr 7, 2026

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
Published on: August 15, 2025
Starting titrating and intensifying metformin
Sanjay Kalra1, Yashdeep Gupta2
1Bharti Hospital, Karnal, Government Medical College and Hospital, Chandigarh, India.
Metformin is the primary oral anti-diabetic drug (OAD) for type 2 diabetes. This guide details starting, adjusting, and intensifying metformin therapy for better patient tolerance and treatment success in primary care settings.
Area of Science:
- Endocrinology
- Pharmacology
- Primary Care Medicine
Background:
- Type 2 diabetes is frequently managed with oral anti-diabetic drugs (OADs).
- Metformin is the established first-line pharmacotherapy for initiating OAD treatment in most patients.
- Effective management requires understanding optimal metformin initiation and titration strategies.
Purpose of the Study:
- To provide guidance on initiating, titrating, and intensifying metformin therapy in primary care.
- To outline methods for improving patient tolerance and adherence to metformin.
- To support clinicians in optimizing metformin use for type 2 diabetes management.
Main Methods:
- Review of current clinical guidelines and evidence for metformin use.
- Discussion of practical approaches for metformin titration and intensification.
- Strategies for managing common side effects and improving patient acceptance.
Main Results:
- Metformin initiation should be gradual to enhance gastrointestinal tolerance.
- Dose titration should be individualized based on glycemic control and patient response.
- Combination therapy may be necessary for intensifying treatment when metformin monotherapy is insufficient.
Conclusions:
- Metformin remains a cornerstone of type 2 diabetes management in primary care.
- Optimizing metformin therapy involves careful titration and strategies to improve tolerability.
- Personalized approaches to metformin use are crucial for achieving treatment goals and improving patient outcomes.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Dipeptidyl Peptidase 4 Inhibitors
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
IV Infusion to Oral Dosing: Conversion Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

